Literature DB >> 31647306

Re-irradiation with protons or heavy ions with focus on head and neck, skull base and brain malignancies.

Katharina Seidensaal1,2,3,4, Semi Ben Harrabi1,2,3,4, Matthias Uhl1,2,3,4, Juergen Debus1,2,3,4,5,6.   

Abstract

Re-irradiation can offer a potentially curative solution in case of progression after initial therapy; however, a second course of radiotherapy can be associated with an increased risk of severe side-effects. Particle therapy with protons and especially carbon ions spares surrounding tissue better than most photon techniques, thus it is of high potential for re-irradiation. Irradiation of tumors of the brain, head and neck and skull base involves several delicate risk organs, e.g. optic system, brainstem, salivary gland or swallowing muscles. Adequate local control rates with tolerable side-effects have been described for several tumors of these locations as meningioma, adenoid cystic carcinoma, chordoma or chondrosarcoma and head and neck tumors. High life time doses nonetheless lead to a different scope of side-effects, e.g. an enhanced rate of carotid blow outs has been reported. This review summarizes the current data on particle irradiation of the aforementioned locations and malignancies.

Entities:  

Mesh:

Year:  2019        PMID: 31647306      PMCID: PMC7066969          DOI: 10.1259/bjr.20190516

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  37 in total

1.  Re-irradiation for recurrent glioma: outcome evaluation, toxicity and prognostic factors assessment. A multicenter study of the Radiation Oncology Italian Association (AIRO).

Authors:  Pierina Navarria; Giuseppe Minniti; Elena Clerici; Stefano Tomatis; Valentina Pinzi; Patrizia Ciammella; Marco Galaverni; Dante Amelio; Daniele Scartoni; Silvia Scoccianti; Marco Krengli; Laura Masini; Lorena Draghini; Ernesto Maranzano; Valentina Borzillo; Paolo Muto; Fabio Ferrarese; Laura Fariselli; Lorenzo Livi; Francesco Pasqualetti; Alba Fiorentino; Filippo Alongi; Michela Buglione di Monale; Stefano Magrini; Marta Scorsetti
Journal:  J Neurooncol       Date:  2018-12-04       Impact factor: 4.130

2.  High control rate in patients with chondrosarcoma of the skull base after carbon ion therapy: first report of long-term results.

Authors:  Matthias Uhl; Matthias Mattke; Thomas Welzel; Jan Oelmann; Gregor Habl; Alexandra D Jensen; Malte Ellerbrock; Thomas Haberer; Klaus K Herfarth; Jürgen Debus
Journal:  Cancer       Date:  2014-02-05       Impact factor: 6.860

3.  Carbon Ion Reirradiation for Recurrent Head and Neck Cancer: A Single-Institutional Experience.

Authors:  Thomas Held; Paul Windisch; Sati Akbaba; Kristin Lang; Rami El Shafie; Denise Bernhardt; Peter Plinkert; Steffen Kargus; Stefan Rieken; Klaus Herfarth; Jürgen Debus; Sebastian Adeberg
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-07-23       Impact factor: 7.038

Review 4.  Retreatment of central nervous system tumours.

Authors:  B Jones; W Grant
Journal:  Clin Oncol (R Coll Radiol)       Date:  2014-05-02       Impact factor: 4.126

5.  Temporal lobe reactions after radiotherapy with carbon ions: incidence and estimation of the relative biological effectiveness by the local effect model.

Authors:  Ingmar Schlampp; Christian P Karger; Oliver Jäkel; Michael Scholz; Bernd Didinger; Anna Nikoghosyan; Angelika Hoess; Michael Krämer; Lutz Edler; Jürgen Debus; Daniela Schulz-Ertner
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-07-16       Impact factor: 7.038

6.  Treatment of salivary gland neoplasms with fast neutron radiotherapy.

Authors:  James G Douglas; Wui-jin Koh; Mary Austin-Seymour; George E Laramore
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2003-09

7.  Proton and carbon ion radiotherapy for primary brain tumors delivered with active raster scanning at the Heidelberg Ion Therapy Center (HIT): early treatment results and study concepts.

Authors:  Stefan Rieken; Daniel Habermehl; Thomas Haberer; Oliver Jaekel; Jürgen Debus; Stephanie E Combs
Journal:  Radiat Oncol       Date:  2012-03-21       Impact factor: 3.481

8.  Clinical Management of Blood⁻Brain Barrier Disruptions after Active Raster-Scanned Carbon Ion Re-Radiotherapy in Patients with Recurrent Head-and-Neck Cancer.

Authors:  Thomas Held; Sati Akbaba; Kristin Lang; Semi Harrabi; Denise Bernhardt; Christian Freudlsperger; Steffen Kargus; Peter Plinkert; Stefan Rieken; Klaus Herfarth; Jürgen Debus; Sebastian Adeberg
Journal:  Cancers (Basel)       Date:  2019-03-19       Impact factor: 6.639

9.  Clinical outcome after particle therapy for meningiomas of the skull base: toxicity and local control in patients treated with active rasterscanning.

Authors:  Rami A El Shafie; Maja Czech; Kerstin A Kessel; Daniel Habermehl; Dorothea Weber; Stefan Rieken; Nina Bougatf; Oliver Jäkel; Jürgen Debus; Stephanie E Combs
Journal:  Radiat Oncol       Date:  2018-03-27       Impact factor: 3.481

10.  Salvage Carbon Ion Radiation Therapy for Locally Recurrent or Radiation-Induced Second Primary Sarcoma of the Head and Neck.

Authors:  Jing Yang; Jing Gao; Xiaodong Wu; Jiyi Hu; Weixu Hu; Lin Kong; Jiade J Lu
Journal:  J Cancer       Date:  2018-06-04       Impact factor: 4.207

View more
  12 in total

1.  Proton therapy special feature: introductory editorial.

Authors:  Kathryn D Held; Antony J Lomax; Esther G C Troost
Journal:  Br J Radiol       Date:  2020-03       Impact factor: 3.039

2.  Ways to unravel the clinical potential of carbon ions for head and neck cancer reirradiation: dosimetric comparison and local failure pattern analysis as part of the prospective randomized CARE trial.

Authors:  Thomas Held; Thomas Tessonnier; Henrik Franke; Sebastian Regnery; Lukas Bauer; Katharina Weusthof; Semi Harrabi; Klaus Herfarth; Andrea Mairani; Jürgen Debus; Sebastian Adeberg
Journal:  Radiat Oncol       Date:  2022-07-08       Impact factor: 4.309

3.  Radiotherapy in the treatment of aggressive fibromatosis: experience from a single institution.

Authors:  K Seidensaal; S B Harrabi; F Weykamp; K Herfarth; T Welzel; G Mechtersheimer; B Lehner; M Schneider; S Fröhling; G Egerer; J Debus; M Uhl
Journal:  Radiat Oncol       Date:  2020-06-05       Impact factor: 3.481

Review 4.  Neuroprotective agents effective against radiation damage of central nervous system.

Authors:  Mária Lalkovicova
Journal:  Neural Regen Res       Date:  2022-09       Impact factor: 5.135

5.  The Efficacy and Safety of Carbon Ion Radiotherapy for Meningiomas: A Systematic Review and Meta-Analysis.

Authors:  Jie-Yun Li; Jing-Wen Li; Yuan-Chang Jin; Mei-Xuan Li; Li-Ping Guo; Zhi-Tong Bing; Qiu-Ning Zhang; Fei Bai; Xiao-Hu Wang; Xiu-Xia Li; Ke-Hu Yang
Journal:  Front Oncol       Date:  2021-05-25       Impact factor: 6.244

6.  Carbon ion reirradiation compared to intensity-modulated re-radiotherapy for recurrent head and neck cancer (CARE): a randomized controlled trial.

Authors:  Thomas Held; Kristin Lang; Sebastian Regnery; Katharina Weusthof; Adriane Hommertgen; Cornelia Jäkel; Eric Tonndorf-Martini; Johannes Krisam; Peter Plinkert; Karim Zaoui; Christian Freudlsperger; Julius Moratin; Jürgen Krauss; Semi B Harrabi; Klaus Herfarth; Jürgen Debus; Sebastian Adeberg
Journal:  Radiat Oncol       Date:  2020-08-05       Impact factor: 3.481

Review 7.  Radiation Therapy for Adenoid Cystic Carcinoma of the Head and Neck.

Authors:  Carlos A Rodriguez-Russo; Jacqueline C Junn; Sue S Yom; Richard L Bakst
Journal:  Cancers (Basel)       Date:  2021-12-17       Impact factor: 6.639

8.  Carbon Ion Dose Constraints in the Head and Neck and Skull Base: Review of MedAustron Institutional Protocols.

Authors:  Piero Fossati; Ana Perpar; Markus Stock; Petra Georg; Antonio Carlino; Joanna Gora; Giovanna Martino; Eugen B Hug
Journal:  Int J Part Ther       Date:  2021-06-25

9.  Proton Therapy for Major Salivary Gland Cancer: Clinical Outcomes.

Authors:  Alexander N Hanania; Xiaodong Zhang; G Brandon Gunn; David I Rosenthal; Adam S Garden; C David Fuller; Jack Phan; Jay P Reddy; Amy Moreno; Gregory Chronowski; Shalin Shah; Noveen Ausat; Ehab Hanna; Renata Ferrarotto; Steven J Frank
Journal:  Int J Part Ther       Date:  2021-06-25

Review 10.  Who Will Benefit from Charged-Particle Therapy?

Authors:  Kyung Su Kim; Hong-Gyun Wu
Journal:  Cancer Res Treat       Date:  2021-06-21       Impact factor: 4.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.